Coherus Oncology Inc — Quarterly Financial Statistics (NASDAQ:CHRS) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics

Quarterly Annual

Cash from operating activities -28.61 M25.83 M46.63 M46.34 M19.72 M 138.51 M Cash from investing activities -542 K17.49 M427.67 M-67.23 M-2.84 M 375.09 M Cash from financing activities -231 K264 K281.52 M-2 000-8.08 M 273.7 M Free cash flow -28.61 M25.83 M46.63 M46.34 M19.72 M 138.51 M

Notícias

Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?

Coherus BioSciences na Conferência Citizens: mudança estratégica para oncologia

Coherus BioSciences at The Citizens Conference: Strategic Oncology Shift

Oppenheimer reafirma classificação de ações da Coherus Biosciences como Outperform

Oppenheimer reiterates Coherus Biosciences stock rating at Outperform

Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript

Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates

Lucro da Coherus BioSciences veio em linha com as projeções; receita menor do que estimativas

Coherus BioSciences earnings matched, revenue fell short of estimates

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q4 Loss, Beats Revenue Estimates

Kiniksa Pharmaceuticals International, plc (KNSA) Misses Q4 Earnings Estimates

Myriad Genetics (MYGN) Q4 Earnings and Revenues Surpass Estimates